🇺🇸 FDA
Patent

US 10173074

Cancer stem cell vaccination and treatment

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 10173074 (Cancer stem cell vaccination and treatment) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/55, A61K2239/57